Ligand validation:4AKB

GAL: beta-D-galactopyranose

GAL is a Ligand Of Interest in 4AKB designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4AKB_GAL_G_1134	79%	80%	0.107	0.953	0.36	0.48	-	-	0	0	100%	0.9525
4AKB_GAL_C_1134	54%	87%	0.159	0.926	0.26	0.42	-	-	0	0	100%	1
4AKB_GAL_E_1134	52%	77%	0.149	0.908	0.32	0.59	-	-	0	0	100%	0.9675
4R6P_GAL_G_202	45%	13%	0.137	0.867	1.66	2.48	4	5	0	0	100%	1
5ELB_GAL_C_202	100%	57%	0.036	0.992	0.82	0.8	-	-	0	0	100%	0.6
4WWH_GAL_B_401	100%	61%	0.047	0.993	0.51	0.97	-	1	0	0	100%	1
3OGR_GAL_A_1024	99%	47%	0.053	0.987	0.79	1.26	-	1	1	0	100%	1
1NSX_GAL_B_2400	98%	50%	0.055	0.981	0.56	1.36	-	3	0	0	100%	1
2EUK_GAL_A_300	98%	59%	0.053	0.973	0.56	0.97	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.